Tilray Brands
Tilray Brands Plunges Amidst Mounting FDA Approval Concerns and Regulatory Headwinds
New York, NY – September 25, 2025 – Tilray Brands Inc. (NASDAQ: TLRY) saw its stock tumble by a significant -5.21% on Thursday, September 25, 2025, as investor confidence continued to erode under the weight of persistent FDA approval uncertainties and a challenging regulatory landscape. This latest decline signals growing apprehension